INmune Bio
Price & Volume
Stats
See moreOpen | $9.22 |
Previous Close | $9.06 |
Day Range | $8.33-$9.64 |
52W Range | $4.32-$14.74 |
Market Cap | $200.8M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $42,000 |
Revenue Growth (YoY) | -63.2% |
Gross Profit (12 Mos) | $42,000 |
Diluted EPS | -$2.18 |
News
See moreYahoo Finance • last year
INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium
Yahoo Finance • last year
INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease
Yahoo Finance • last year
INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe
Yahoo Finance • last year
INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update
About
CEO | Dr. Raymond Joseph Tesi M.D. |
CFO | Mr. David J. Moss M.B.A. |
Address | 225 NE Mizner Blvd., Boca Raton, FL, United States, 33432 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
